Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$20.09 - $35.8 $80,339 - $143,164
-3,999 Reduced 28.15%
10,208 $214,000
Q2 2022

Jul 26, 2022

BUY
$27.42 - $43.63 $221,553 - $352,530
8,080 Added 131.88%
14,207 $441,000
Q1 2022

Apr 27, 2022

SELL
$36.48 - $52.22 $19,772 - $28,303
-542 Reduced 8.13%
6,127 $252,000
Q4 2021

Jan 31, 2022

SELL
$33.11 - $55.01 $155,252 - $257,941
-4,689 Reduced 41.28%
6,669 $290,000
Q3 2021

Nov 03, 2021

SELL
$50.07 - $66.05 $130,031 - $171,531
-2,597 Reduced 18.61%
11,358 $569,000
Q1 2021

Apr 29, 2021

SELL
$86.23 - $125.19 $112,702 - $163,623
-1,307 Reduced 8.56%
13,955 $1.3 Million
Q4 2020

Jan 28, 2021

BUY
$79.17 - $111.47 $461,877 - $650,315
5,834 Added 61.88%
15,262 $1.37 Million
Q3 2020

Oct 29, 2020

BUY
$81.91 - $134.94 $176,679 - $291,065
2,157 Added 29.67%
9,428 $974,000
Q2 2020

Jul 24, 2020

SELL
$54.33 - $89.52 $243,615 - $401,407
-4,484 Reduced 38.15%
7,271 $575,000
Q1 2020

Apr 29, 2020

SELL
$49.34 - $68.76 $800,837 - $1.12 Million
-16,231 Reduced 58.0%
11,755 $680,000
Q3 2019

Oct 28, 2019

BUY
$40.6 - $57.2 $750,085 - $1.06 Million
18,475 Added 194.25%
27,986 $1.46 Million
Q2 2019

Jul 30, 2019

SELL
$39.92 - $53.86 $176,885 - $238,653
-4,431 Reduced 31.78%
9,511 $459,000
Q1 2019

Apr 30, 2019

SELL
$48.23 - $66.16 $34,002 - $46,642
-705 Reduced 4.81%
13,942 $704,000
Q4 2018

Feb 01, 2019

SELL
$55.63 - $73.24 $1.06 Million - $1.4 Million
-19,092 Reduced 56.59%
14,647 $868,000
Q3 2018

Nov 05, 2018

BUY
$52.05 - $66.51 $1.01 Million - $1.3 Million
19,486 Added 136.72%
33,739 $2.22 Million
Q1 2018

May 02, 2018

SELL
$44.44 - $54.39 $499,505 - $611,343
-11,240 Reduced 44.09%
14,253 $750,000
Q4 2017

Jan 31, 2018

BUY
$37.77 - $47.75 $962,870 - $1.22 Million
25,493
25,493 $1.19 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.